Comments on India’s draft biotech patent guidelines posted

Peter Leung, Hong Kong


The India Patent Office has released public feedback to its draft guidelines for the examination of biotechnology patents

The guidelines were released on December 11 2013 with a public comment period until January 11. The Patent Office received comments from Indian biotechnology firms, patent law firms, and groups such as the Organisation of Pharmaceuticals Producers of India (OPPO), the Biotechnology Industry Organization (BIO) and even the Japan Intellectual Property...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Three new patent attorney partners for @finneganIPLaw in London - details http://t.co/bfciijxZUU

Sep 18 2014 01:52 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @OliviaLuk1: @ManagingIP can't do it but that sounds awesome for a younger professional!

Sep 18 2014 01:46 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @abaipl: USPTO Expected to Issue Revised Myriad-Mayo Guidance in October http://t.co/s9XpmB1PH7 @PatentDocs #patent

Sep 18 2014 12:18 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


AIPPI Congress News 2014

Read this year's AIPPI Congress News - published daily by Managing IP direct from the AIPPI Annual Meeting in Toronto
null null null

September 2014

The surprising rise of the PTAB

Patent owners have been shocked at how popular IPR proceedings at the PTAB have proven. As the USPTO mulls over changes and the Federal Circuit braces itself for a deluge of appeals, Michael Loney reports on how the PTAB is likely to evolve



Most read articles

Supplements